Literature DB >> 24732679

Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer.

F Gallivanone1, C Canevari, I Sassi, V Zuber, A Marassi, L Gianolli, M Picchio, C Messa, M C Gilardi, I Castiglioni.   

Abstract

AIM: The aim of this paper was to assess the prognostic role of pretherapy partial volume corrected (PVC) 18F-fluorodeoxyglucose mean standardized uptake value (SUV) in breast cancer (BC).
METHODS: Forty oncological patients, BC diagnosed by biopsy, with breast tumor mass diameter >1 cm measured to the mammography, designed for surgical intervention, underwent a pretherapy semi-quantitative 18F-FDG positron emission tomography/computed tomography (18F-FDG PET/CT) whole-body study for tumor staging. Mean Body-Weight Standardized Uptake Value with Correction for Partial Volume effect (PVC- SUVBW-mean) was calculated in all mammary detected lesions. Excised tissues from primitive BC were sectioned and classified according to the WHO guidelines, evaluating biological features. Univariate (Mann-Withney/Kruskal-Wallis) and multivariate (linear regression, hierarchical clustering) statistical tests were performed between PVC-SUVBW-mean and biological indexes. ROC analysis was performed. PVC-SUVBW-mean thresholds were derived allowing to distinguish groups of BC patients with different biological characteristics. Specificity and Sensitivity were also calculated.
RESULTS: Statistical and multiple correlations between pretherapy 18F-FDG PET PVC-SUVBW-mean and histological type, grade, ER/PgR hormone receptors and Mib-1 cellular proliferation index were found. In our samples, PVC-SUVBW-mean <≈4 g/cc was found correlated to BC patients with Invasive Lobular Carcinoma (ILC) or well differentiated Invasive Ductal Carcinoma (IDC), a positive expression of ER and PgR and a negative expression of MiB-1, while PVC-SUVBW-mean >≈7.00 is associated to BC patients with moderately and poorly differentiated IDC, negative expression of ER and PgR and a positive expression of MiB-1.
CONCLUSION: Pretherapy PVC 18F-FDG PET PVC-SUVBW-mean measurement correlates with prognostic factors in BC and could be used to stratify patients before intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24732679

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  8 in total

1.  [18F]FDG PET/CT features for the molecular characterization of primary breast tumors.

Authors:  Lidija Antunovic; Francesca Gallivanone; Martina Sollini; Andrea Sagona; Alessandra Invento; Giulia Manfrinato; Margarita Kirienko; Corrado Tinterri; Arturo Chiti; Isabella Castiglioni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-15       Impact factor: 9.236

2.  AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics.

Authors:  Isabella Castiglioni; Francesca Gallivanone; Paolo Soda; Michele Avanzo; Joseph Stancanello; Marco Aiello; Matteo Interlenghi; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-11       Impact factor: 9.236

Review 3.  The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.

Authors:  Koosha Paydary; Siavash Mehdizadeh Seraj; Mahdi Zirakchian Zadeh; Sahra Emamzadehfard; Sara Pourhassan Shamchi; Saeid Gholami; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

4.  FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation.

Authors:  Mathieu Sinigaglia; Besma Mahida; Eve Piekarski; Renata Chequer; Nidaa Mikail; Khadija Benali; Fabien Hyafil; Dominique Le Guludec; François Rouzet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-25       Impact factor: 9.236

5.  Biomarkers from in vivo molecular imaging of breast cancer: pretreatment 18F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy.

Authors:  Francesca Gallivanone; Marta Maria Panzeri; Carla Canevari; Claudio Losio; Luigi Gianolli; Francesco De Cobelli; Isabella Castiglioni
Journal:  MAGMA       Date:  2017-02-28       Impact factor: 2.310

6.  Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel.

Authors:  E Quaquarini; D D'Ambrosio; F Sottotetti; F Gallivanone; M Hodolic; P Baiardi; R Palumbo; C Vellani; C Canevari; A Bernardo; I Castiglioni; C Porta; G Trifirò
Journal:  Contrast Media Mol Imaging       Date:  2019-03-26       Impact factor: 3.161

7.  Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.

Authors:  Christina Baun; Kirsten Falch; Oke Gerke; Jeanette Hansen; Tram Nguyen; Abass Alavi; Poul-Flemming Høilund-Carlsen; Malene G Hildebrandt
Journal:  BMC Med Imaging       Date:  2018-05-09       Impact factor: 1.930

8.  Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic Lesions.

Authors:  Francesca Gallivanone; Matteo Interlenghi; Daniela D'Ambrosio; Giuseppe Trifirò; Isabella Castiglioni
Journal:  Contrast Media Mol Imaging       Date:  2018-09-10       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.